These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 751007)

  • 1. Effect of Venoruton on the factor XIII activity in rat plasma.
    Grochal M; Sempińska-Edelberg E; Plewiński J
    Pol J Pharmacol Pharm; 1978; 30(5):659-63. PubMed ID: 751007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of O-(beta-hydroxyethyl)-rutosides (HR) on the skin capillary resistance of rats.
    Gábor M
    Arzneimittelforschung; 1981; 31(3):442-5. PubMed ID: 7194669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of hydroxyethylrutosides (HR): metabolism of [14C]-HR in man.
    Hackett AM; Griffiths LA; Luyckx AS; van Cauwenberge H
    Arzneimittelforschung; 1976; 26(5):925-8. PubMed ID: 989368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of O-(beta-hydroxyethyl)-rutosides on function and structure of the ganglion cells.
    Blasius W; Leusser K; Merker G
    Arzneimittelforschung; 1976; 26(9):1645-50. PubMed ID: 1036693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dose schedule of vitamin E and hydroxethylruticide on intestinal toxicity induced by adriamycin.
    McGinness JE; Grossie B; Proctor PH; Benjamin RS; Gulati OP; Hokanson JA
    Physiol Chem Phys Med NMR; 1986; 18(1):17-24. PubMed ID: 3774891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticatatonic effect of venoruton.
    Aley KO; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1988 Apr; 10(4):263-5. PubMed ID: 2898576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O-(beta-hydroxyethyl)-rutoside (Venoruton) fails to block histamine or bradykinin-induced edema formation in the canine forelimb perfused at constant arterial inflow.
    Dobbins DE; Soika CY; Dabney JM
    Microcirc Endothelium Lymphatics; 1984 Oct; 1(5):509-23. PubMed ID: 6546155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. o-(beta-Hydroxyethyl)-rutoside-mediated protection of renal injury associated with cis-diamminedichloroplatinum(II)/hyperthermia treatment.
    Bull JM; Strebel FR; Sunderland BA; Bulger RE; Edwards M; Siddik ZH; Newman RA
    Cancer Res; 1988 Apr; 48(8):2239-44. PubMed ID: 3349489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of mono-3'- and mono-4'-0-(beta-hydroxyethyl)-rutoside derivatives, after single doses of Venoruton powder in healthy volunteers.
    Kienzler JL; Sallin D; Schifflers MH; Ghika A
    Eur J Clin Pharmacol; 2002 Sep; 58(6):395-402. PubMed ID: 12242598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma and platelet fibrin-stabilizing factor activity in rats intoxicated with phenylmercuric acetate.
    Michalska M; Wierzbicki R
    Pol J Pharmacol Pharm; 1984; 36(6):611-5. PubMed ID: 6535154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of O-(beta-hydroxyethyl)-rutoside (venoruton) on the adherence of leukocytes in patients with arteriosclerosis obliterans of the lower limbs].
    Lukjan H; Szpak A; Bodzenta A; Bielawiec M; Rosc D; Chyzy R
    Pol Arch Med Wewn; 1985 Jun; 73(6):345-50. PubMed ID: 3880372
    [No Abstract]   [Full Text] [Related]  

  • 13. [Venoruton--used not only in venopathies? Symposium on O-(beta-hydroxyethyl)-rutoside (=Venoruton) in vascular diseases].
    ZFA (Stuttgart); 1981 Sep; 57(26):1758-60. PubMed ID: 7303836
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of HR (O-Beta-Hydroxyethylo-Rutoside, Venoruton) on the deformability of erythrocytes in patients with arteriosclerosis obliterans of lower limbs.
    Lukjan H; Rość D; Chyzy R; Bodzenta A; Szpak A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):191-6. PubMed ID: 2581865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of O-(beta-hydroxyethyl)-rutoside on wound healing in the rat.
    Wilhelmi G
    Pharmacology; 1979; 19(2):82-5. PubMed ID: 531085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in the hematological profile in rat following whole body gamma radiation with and without venoruton pretreatment.
    Kanwar KC; Verma A
    J Environ Pathol Toxicol Oncol; 1992; 11(4):235-9. PubMed ID: 1507075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of O-(beta-hydroxyethyl)-rutosides (HR) against adriamycin-induced toxicity in rats.
    Gulati OP; Nordmann H; Aellig A; Maignan MF; McGinness J
    Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):323-34. PubMed ID: 4004421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Venoruton and capillary permeability].
    Cesarone MR; Laurora G; Gabini M; Errichi BM; Candiani C; Belcaro G
    Minerva Cardioangiol; 1989 May; 37(5):265-8. PubMed ID: 2779806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Capillary resistance raising action of Venoruton. Experimental data on the therapeutic effects of Venoruton].
    Gábor M
    Acta Pharm Hung; 1983 May; 53(3):115-20. PubMed ID: 6880764
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardioprotective properties of O-(beta-hydroxyethyl)-rutosides in doxorubicin-pretreated BALB/c mice.
    van Acker SA; Voest EE; Beems DB; Madhuizen HT; de Jong J; Bast A; van der Vijgh WJ
    Cancer Res; 1993 Oct; 53(19):4603-7. PubMed ID: 8402634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.